| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/20/2010 | EP0917538B1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications |
| 01/20/2010 | CN101631562A Compound and device for treating bone and/or cartilage defects |
| 01/20/2010 | CN101631561A Protective agent for transplanted organ |
| 01/20/2010 | CN101631560A Use of pegylated IL-10 to treat cancer |
| 01/20/2010 | CN101631559A Use of Semaphorin 6A for Promoting Myelination and Oligodendrocyte Differentiation |
| 01/20/2010 | CN101631558A Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes, the uses and treating mode thereof |
| 01/20/2010 | CN101628113A Application of earthworm fibrinolytic enzyme in resistance to liver fibrosis |
| 01/20/2010 | CN101628112A Medicament composition for supplementing calcium |
| 01/20/2010 | CN101628111A TACI-immunoglobulin fusion proteins |
| 01/20/2010 | CN101628110A Use of fungal immunomodulatory protein |
| 01/20/2010 | CN101628109A Compound neomycin sulphate solution and preparation method thereof |
| 01/20/2010 | CN100582782C Plasma urotensin in human heart failure |
| 01/20/2010 | CN100582121C 胸腺素β4衍生物及其应用 Thymosin β4 derivative and its applications |
| 01/20/2010 | CN100582117C Compositions for DNA mediated gene silencing |
| 01/20/2010 | CN100581584C Serine protease inhibitor of Rana grahami, and its application |
| 01/19/2010 | US7650243 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 01/19/2010 | US7649088 Diagnosis and treatment of Hereditary Spastic Paraplegia |
| 01/19/2010 | US7649084 Genetic engineering; cat thyrotropin beta -subunit polypeptide and polynucleotide; hyperthyroidism |
| 01/19/2010 | US7649082 Glial-derived neurotrophic factor (GDNF)/neurturin family of growth factors; Neurodegenerative disorders; used in preventing the atrophy, degeneration or death of certain cells, in particular neurons |
| 01/19/2010 | US7649080 Reacting vancomycin with a coupling reagent, then reacting with a cephalosporin derivative; making antibiotic effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
| 01/19/2010 | US7649023 Using polyoxyethylene glycol solutions; mixing with drug |
| 01/19/2010 | US7649000 (2'S,2''R)-4-(2'-(2''-amino-3''-(4'''-ethoxyphenyl)propanoylamino)-3'-phenylpropanoyl-amino)piperidine- 1-carboxamidine; inflammatory bowel disease, arthritis, inflammation, septic shock, hypotension, cancer, adult respiratory distress syndrome, disseminated intravascular coagulation |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/19/2010 | US7648965 Method for fostering bone formation and preservation |
| 01/19/2010 | US7648964 In response to an insult or injury, in protecting against ocular inflammation, and in promoting ocular wound repair; glycoprotein |
| 01/19/2010 | US7648963 Molecules of the PYRIN/NBS/LRR protein family and uses thereof |
| 01/19/2010 | US7648962 which retain activity for stimulating cyclic guanosine monophosphate production and binding to natriuretic peptide receptor type A; improved bioavailability and half-life in circulation; for treatment of congestive heart failure |
| 01/19/2010 | US7648961 Use of somatostatin or one of its analogues for preparing a medicament intended to regulate the ovarian follicular reserve in non-menopausal women |
| 01/19/2010 | US7648960 Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles |
| 01/19/2010 | US7648959 Methods and compositions for the treatment of diseases of the eye |
| 01/19/2010 | US7648958 Factor VIII/vWF-complex and methods of purifying same |
| 01/19/2010 | US7648957 Comprising a peptide fraction which is preferably rich in di- and tripeptides in combination with an insulin sensitizer, preferably a natural or pharmaceutical insulin sensitizer; suitable as pharmaceutical or food or a food supplement; especially useful for Type 2 diabetes |
| 01/19/2010 | US7648827 Use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferative diseases |
| 01/19/2010 | US7648826 Detecting CYP24 expression level as a marker for predisposition to cancer |
| 01/19/2010 | US7648704 Diagnosis and treatment of human dormancy syndrome |
| 01/19/2010 | US7648702 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
| 01/19/2010 | US7648701 Peptide composition as immunogen for the treatment of allergy |
| 01/19/2010 | US7648700 Inducing rapid bone formation; contains bone anabolic agent and a mechanical alteration device for altering contents of a bone marrow cavity |
| 01/19/2010 | US7648677 Method for operating a reservoir-based sensor device |
| 01/19/2010 | CA2551157C Novel kappa receptor selective opioid peptides |
| 01/19/2010 | CA2466869C Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 01/19/2010 | CA2464243C Method and composition for dry eye treatment |
| 01/19/2010 | CA2393466C Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 01/19/2010 | CA2373255C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 01/19/2010 | CA2335107C Leptin-mediated gene-induction |
| 01/19/2010 | CA2319640C Electrochemically reactive cathodes for an electrotransport device |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/19/2010 | CA2235412C Pharmaceutical composition containing an activin or inhibin stimulator |
| 01/19/2010 | CA2183620C Sustained release composition |
| 01/19/2010 | CA2164517C Method of treating retained pulmonary secretions |
| 01/19/2010 | CA2123492C Lymphoid antigen cd30 |
| 01/14/2010 | WO2010006343A2 Glycopeptide constructs and uses thereof |
| 01/14/2010 | WO2010006267A2 Cyclic tetrapeptides |
| 01/14/2010 | WO2010006236A1 Delivery of dry formulations of octreotide |
| 01/14/2010 | WO2010006200A2 Triggered release of drugs from polymer particles |
| 01/14/2010 | WO2010006117A2 Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 01/14/2010 | WO2010006060A2 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof |
| 01/14/2010 | WO2010005693A1 Cyclized ngr peptide compounds, compositions, and methods of their use |
| 01/14/2010 | WO2010005575A2 Nanotube-reinforced balloons for delivering therapeutic agents within or beyond the wall of blood vessels, and methods of making and using same |
| 01/14/2010 | WO2010005565A2 Method of treating glycogen storage disease |
| 01/14/2010 | WO2010005557A2 Biological therapeutic compositions and methods thereof |
| 01/14/2010 | WO2010005533A2 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| 01/14/2010 | WO2010005529A2 Once-a-day rna-polymerase inhibiting and elongation factor g (ef-g) inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by methicillin-resistant staphylococcus aureus |
| 01/14/2010 | WO2010005513A2 Crystal structure of staphylococcus aureus clumping factor a in complex with fibrinogen derived peptide and uses thereof |
| 01/14/2010 | WO2010005389A1 Oxidized ldl specific antibody-fusion and conjugated proteins |
| 01/14/2010 | WO2010005344A1 Nanosomal pharmaceutical form of a long acting preparation for treating hepatitis c (variants) |
| 01/14/2010 | WO2010005310A2 Complement antagonists and uses thereof |
| 01/14/2010 | WO2010005296A1 Polypeptides involved in the neuroregeneration-promoting properties of olfactory ensheathing glia |
| 01/14/2010 | WO2010005293A1 Peptidylarginine deiminase (pad) inhibitors |
| 01/14/2010 | WO2010005123A1 Composition for enhancing biosynthesis of hyaluronic acid or glycosaminoglycan comprising orotic acid, a salt thereof, or a derivative thereof |
| 01/14/2010 | WO2010005069A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | WO2010005068A1 Pharmaceutical composition for treatment and prevention of cancer |
| 01/14/2010 | WO2010005047A1 Intestinal environment-improving agent |
| 01/14/2010 | WO2010005046A1 Anti-angiogenic agent |
| 01/14/2010 | WO2010005012A1 Apolactoferrin-containing composition |
| 01/14/2010 | WO2010004535A2 Therapeutic methods and compositions employing peptide compounds |
| 01/14/2010 | WO2010004367A1 Use of a mixture of superoxide dismutase and catalase for treating pruritus and alleviating its symptoms |
| 01/14/2010 | WO2010004299A2 Composition |
| 01/14/2010 | WO2010004292A1 Chimaeric peptide |
| 01/14/2010 | WO2010004003A2 Modified peptides as potent inhibitors of the psd-95/nmda receptor interaction |
| 01/14/2010 | WO2010003939A1 Use of pasireotide for the treatment of endogenous hyperinsulinemic hypoglycemia |
| 01/14/2010 | WO2010003687A1 Von willebrand factor or factor viii and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes |
| 01/14/2010 | WO2010003668A2 Treatment of solid tumors with tissue inhibitors of metalloproteinases (timps) |
| 01/14/2010 | WO2010003601A1 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use |
| 01/14/2010 | WO2010003520A2 Anti-tumor immunotherapy |
| 01/14/2010 | WO2010003279A2 A cryosurgery anticancer antigen preparation and its preparation method |
| 01/14/2010 | WO2010003240A1 Gmcsf and truncated ccl2 conjugates and methods and uses thereof |
| 01/14/2010 | WO2010003231A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 01/14/2010 | WO2010003193A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 01/14/2010 | WO2010003178A1 A synthetic vaccine component |
| 01/14/2010 | WO2009143380A3 Methods for treating progressive cognitive disorders related to neurofibrillary tangles |
| 01/14/2010 | WO2009143285A3 Exendins to lower cholestrol and triglycerides |
| 01/14/2010 | WO2009143268A3 Treatment of mitochondrial diseases with an erythropoietin mimetic |
| 01/14/2010 | WO2009143101A3 Gastrin releasing peptide compounds |
| 01/14/2010 | WO2009143023A3 Neoplasia targeting peptides and methods of using the same |
| 01/14/2010 | WO2009142679A3 Methods for treating acute myocardial infarction |
| 01/14/2010 | WO2009140416A3 Treatment for epilepsy |
| 01/14/2010 | WO2009137649A3 Methods for treating thyroid cancer |
| 01/14/2010 | WO2009128917A3 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| 01/14/2010 | WO2009120371A3 Computationally designed inhibitors of amyloidosis |